Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

Rituximab monotherapy in splenic marginal zone lymphoma: prolonged responses and potential benefit from maintenance

Blood (2018) 132 (6): 666–670.

https://doi.org/10.1182/blood-2018-02-833608

Published: 2018

Journal Articles

Deep-Sequencing Reveals the Molecular Landscape of Splenic Marginal Zone Lymphoma: Biological and Clinical Implications

Blood (2014) 124 (21): 76.

https://doi.org/10.1182/blood.V124.21.76.76

Published: 2014

Journal Articles

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) of the Salivary Gland Is Associated with Improved Prognosis When Arising in a Background of Sjögren’s Disease and May Not Benefit from Local Therapy

Amie E Jackson, MD, Michael Mian, Christina H. Kalpadakis, MD, Gerassimos A Pangalis, MD, Anastasios Stathis, MD, Elena Porro, MSc, Ellen D McPhail, MD, Thomas M Habermann, MD, Kay M. Ristow, Franco Cavalli, MD, Grzegorz S. Nowakowski, MD, Emanuele Zucca, MD

Blood (2014) 124 (21): 1637.

https://doi.org/10.1182/blood.V124.21.1637.1637

Published: 2014

Journal Articles

Clonal B-cell lymphocytosis exhibiting immunophenotypic features consistent with a marginal-zone origin: is this a distinct entity?

Blood (2014) 123 (8): 1199–1206.

https://doi.org/10.1182/blood-2013-07-515155

Published: 2014

Journal Articles

Poly [ADP-Ribose] Polymerase 1 (PARP-1) Expression Before and After Immunochemotherapy In Patients With B Chronic Lymphocytic Leukemia

Panagiotis Theodorou Diamantopoulos, Maria Sofotasiou, Vasiliki Papadopoulou, Katerina Polonyfi, Theodoros Iliakis, Fani Kalala, Konstantinos Zervakis, Niki Rougala, Nefeli Giannakopoulou, Xenia Hatzinikolaou, Athanassios Galanopoulos, Eleni Variami, Gerassimos A Pangalis, Nora-Athina Viniou

Blood (2013) 122 (21): 5293.

https://doi.org/10.1182/blood.V122.21.5293.5293

Published: 2013

Journal Articles

Significance of Serum Free Light Chains in Chronic Lymphocytic Leukemia (cll) Prognosis

Blood (2012) 120 (21): 4568.

https://doi.org/10.1182/blood.V120.21.4568.4568

Published: 2012

Journal Articles

A Study of the Hereditary Hyperferritinemia Cataract Syndrome in Patients of Greek Origin

Stamatia-Lydia Hatzinicolaou, Danai Palaiologou, Antonios G Antoniadis, Georgios Papanikolaou, Nikolaos Sakellaropoulos, Gerassimos A Pangalis, John Meletis, Antonios Kattamis

Blood (2012) 120 (21): 3205.

https://doi.org/10.1182/blood.V120.21.3205.3205

Published: 2012

Journal Articles

Lower Levels of Survivin in Patients with Leukemic Low Grade B-Cell Lymphomas Expressing LMP1 Oncoprotein of Epstein-Barr Virus

Panagiotis Theodorou Diamantopoulos, Katerina Polonyphi, Maria Sofotasioiu, Athanassios Galanopoulos, Nikolaos Spanakis, George Rassidakis, MD, PhD, Panagiotis Kouzis, Vassiliki Papadopoulou, Fani Kalala, Theodoros Iliakis, Theodoros Vassilakopoulos, Maria K. Angelopoulou, Marina Siakantaris, M.D., Evangelos Terpos, Eleni Variami, Panagoula Kollia, Gerassimos A Pangalis, Nora-Athina Viniou

Blood (2012) 120 (21): 1560.

https://doi.org/10.1182/blood.V120.21.1560.1560

Published: 2012

Journal Articles

The Addition of sFLCR Improves ISS Prognostication in Multiple Myeloma (MM).

Blood (2007) 110 (11): 1490.

https://doi.org/10.1182/blood.V110.11.1490.1490

Published: 2007

Journal Articles

Bone Remodeling in Patients with Relapsed/Refractory Multiple Myeloma Who Receive Lenalidomide-Based Regimens.

Evangelos Terpos, Dimitrios Christoulas, Efstathios Kastritis, Eirini Katodritou, Xenophon Papanikolaou, Maria Roussou, Nikolaos Stavropoulos, Konstantinos Tsionos, Gerassimos A. Pangalis, Konstantinos Zervas, Orhan Sezer, Meletios A. Dimopoulos

Blood (2007) 110 (11): 4745.

https://doi.org/10.1182/blood.V110.11.4745.4745

Published: 2007

Journal Articles

Serum Free Light Chain Ratio (FLCR) at Diagnosis Constitute a Powerful Prognostic Factor of Survival in Multiple Myeloma (MM).

Marie-Christine Kyrtsonis, MD, Theodoros P. Vassilakopoulos, MD, Nicoletta Kafasi, MD, Sotirios Sachanas, MD, Tatiana Tzenou, MD, Argiroula Papadogiannis, MD, Zacharoula Galanis, MD, Christina Kalpadakis, MD, Maria Dimou, MD, Elias Kyriakou, MD, Maria K. Angelopoulou, MD, Maria N. Dimopoulou, MD, Marina P. Siakantaris, MD, Styliani I. Kokoris, MD, Evangelia M. Dimitriadou, MD, Panayiotis Panayiotidis, MD, Gerassimos A. Pangalis, MD

Blood (2006) 108 (11): 3522.

https://doi.org/10.1182/blood.V108.11.3522.3522

Published: 2006

Journal Articles

B-Chronic Lymphoproliferative Disorders (BCLD) Presenting with Splenomegaly: Differential Diagnosis and Outcome.

Maria K. Angelopoulou, MD, Maria Papakonstantinou, MD, Flora N. Kontopidou, MD, Maria N. Dimopoulou, MD, Marina P. Siakantaris, MD, Theodoros P. Vassilakopoulos, MD, Christina Kalpadakis, MD, Styliani Kokoris, MD, Evangelia M. Dimitriadou, MD, Zacharoula Galani, MD, Sotirios Sachanas, MD, Padelis Tsirkinidis, MD, Marie-Christine Kyrtsonis, MD, Penelope Korkolopoulou, MD, Panayiotis Panayiotidis, MD, Gerassimos A. Pangalis, MD

Blood (2006) 108 (11): 4655.

https://doi.org/10.1182/blood.V108.11.4655.4655

Published: 2006

Journal Articles

Evaluation of Microsatellite Instability in Gastric MALT Lymphomas.

Marina P. Siakantaris, MD, Maria K. Angelopoulou, MD, Konstantinos Lilakos, Yannis Metaxas, MD, Maria Moschoyianni, MD, Maria Gamaletsou, MD, Theodoros P. Vassilakopoulos, MD, Marie-Christine Kyrtsonis, MD, Penelope Korkolopoulou, MD, Panayiotis Panayiotidis, MD, Gerassimos A. Pangalis, MD

Blood (2006) 108 (11): 4625.

https://doi.org/10.1182/blood.V108.11.4625.4625

Published: 2006

Journal Articles

Long Term Follow up of Hairy Cell Leukemia (HCL) Patients (PTS) Treated with Interferon-Alpha (IFN-α). The Importance of Maintenance.

Sotirios Sachanas, Maria K. Angelopoulou, Konstantinos Anargyrou, Styliani I. Kokoris, Theodoros P. Vassilakopoulos, Zacharoula I. Galani, Evangelia M. Dimitriadou, Marina P. Siakantaris, Maria N. Dimopoulou, Flora N. Kontopidou, Marie-Christine Kyrtsonis, Eleni Plata, Panayiotis Tsaftaridis, Panayiotis Panayiotidis, Gerassimos A. Pangalis

Blood (2006) 108 (11): 4718.

https://doi.org/10.1182/blood.V108.11.4718.4718

Published: 2006

Journal Articles

Efficacy of Rituximab in Hairy Cell Leukemia.

Styliani I. Kokoris, Maria K. Angelopoulou, Zacharoula I. Galani, Konstantinos Anargyrou, Sotirios Sachanas, Theodoros P. Vassilakopoulos, Marina P. Siakantaris, Flora N. Kontopidou, Evangelia M. Dimitriadou, Maria N. Dimopoulou, Panayiotis Tsaftaridis, Eleni Plata, Christina Kalpadakis, Marie-Christine Kyrtsonis, Panayiotis Panayiotidis, Gerassimos A. Pangalis

Blood (2006) 108 (11): 4719.

https://doi.org/10.1182/blood.V108.11.4719.4719

Published: 2006

Journal Articles

The Successful Use of Archived Formalin-Fixed Paraffin-Embedded (FFPE) Material for Gene Expression Studies.

Konstantinos Lilakos, Maria K. Angelopoulou, MD, George Georgiou, MD, Vassilios Salpeas, PhD, Penelope Korkolopoulou, MD, Panayiotis Panayiotidis, MD, Gerassimos A. Pangalis, MD

Blood (2006) 108 (11): 4637.

https://doi.org/10.1182/blood.V108.11.4637.4637

Published: 2006

Journal Articles

Rituximab-CHOP (R-CHOP) and Radiotherapy (RT) for Primary Mediastinal Large B-Cell Lymphoma (PMLBCL).

Blood (2006) 108 (11): 2745.

https://doi.org/10.1182/blood.V108.11.2745.2745

Published: 2006

Journal Articles

Z-Guggulsterone Downregulates Survivin and Induces Cell Death in Large B Cell Lymphoma Cells In Vitro.

Maria K. Angelopoulou, MD, Konstantinos Lilakos, Vassilios Salpeas, PhD, Sotirios Sachanas, MD, Penelope Korkolopoulou, MD, Marina P. Siakantaris, MD, Theodoros P. Vassilakopoulos, MD, Panayiotis Panayiotidis, MD, Gerassimos A. Pangalis, MD

Blood (2006) 108 (11): 4752.

https://doi.org/10.1182/blood.V108.11.4752.4752

Published: 2006

Journal Articles

Serum Soluble Syndecan-1 Levels at Diagnosis Constitute an Independent Prognostic Factor of Survival in Myeloma That May Further Differentiate Patients within the ISS Stages.

Marie-Christine Kyrtsonis, MD, Theodoros P. Vassilakopoulos, MD, Argyro Papadogiannis, MD, Tatiana Tzenou, MD, Christina Kalpadakis, MD, Antoine Antoniadis, MD, Maria N. Dimopoulou, MD, Marina P. Siakantaris, MD, Stella I. Kokoris, MD, Evangelia M. Dimitriadou, MD, Maria K. Angelopoulou, MD, Ellen Plata, MD, Panagiotis Tsaftaridis, MD, Gerassimos A. Pangalis, MD

Blood (2005) 106 (11): 3404.

https://doi.org/10.1182/blood.V106.11.3404.3404

Published: 2005

Journal Articles

Rituximab Monotherapy Is an Effective Treatment for Splenic Marginal Zone B-Cell Lymphomas (SMZL).

Maria N. Dimopoulou, MD, Christina Kalpadakis, MD, Evangelia M. Dimitriadou, MD, Marie-Christine Kyrtsonis, MD, Styliani I. Kokoris, MD, Panagiotis Tsaftaridis, MD, Flora N. Kontopidou, MD, Marina P. Siakantaris, MD, Eleni Plata, MD, Theodoros P. Vassilakopoulos, MD, Maria K. Angelopoulou, MD, Gerassimos A. Pangalis, MD.

Blood (2005) 106 (11): 4800.

https://doi.org/10.1182/blood.V106.11.4800.4800

Published: 2005

NARROW

Rituximab monotherapy in splenic marginal zone lymphoma: prolonged responses and potential benefit from maintenance

Deep-Sequencing Reveals the Molecular Landscape of Splenic Marginal Zone Lymphoma: Biological and Clinical Implications

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) of the Salivary Gland Is Associated with Improved Prognosis When Arising in a Background of Sjögren’s Disease and May Not Benefit from Local Therapy

Clonal B-cell lymphocytosis exhibiting immunophenotypic features consistent with a marginal-zone origin: is this a distinct entity?

Poly [ADP-Ribose] Polymerase 1 (PARP-1) Expression Before and After Immunochemotherapy In Patients With B Chronic Lymphocytic Leukemia

Significance of Serum Free Light Chains in Chronic Lymphocytic Leukemia (cll) Prognosis

A Study of the Hereditary Hyperferritinemia Cataract Syndrome in Patients of Greek Origin

Lower Levels of Survivin in Patients with Leukemic Low Grade B-Cell Lymphomas Expressing LMP1 Oncoprotein of Epstein-Barr Virus

The Addition of sFLCR Improves ISS Prognostication in Multiple Myeloma (MM).

Bone Remodeling in Patients with Relapsed/Refractory Multiple Myeloma Who Receive Lenalidomide-Based Regimens.

Serum Free Light Chain Ratio (FLCR) at Diagnosis Constitute a Powerful Prognostic Factor of Survival in Multiple Myeloma (MM).

B-Chronic Lymphoproliferative Disorders (BCLD) Presenting with Splenomegaly: Differential Diagnosis and Outcome.

Evaluation of Microsatellite Instability in Gastric MALT Lymphomas.

Long Term Follow up of Hairy Cell Leukemia (HCL) Patients (PTS) Treated with Interferon-Alpha (IFN-α). The Importance of Maintenance.

Efficacy of Rituximab in Hairy Cell Leukemia.

The Successful Use of Archived Formalin-Fixed Paraffin-Embedded (FFPE) Material for Gene Expression Studies.

Rituximab-CHOP (R-CHOP) and Radiotherapy (RT) for Primary Mediastinal Large B-Cell Lymphoma (PMLBCL).

Z-Guggulsterone Downregulates Survivin and Induces Cell Death in Large B Cell Lymphoma Cells In Vitro.

Serum Soluble Syndecan-1 Levels at Diagnosis Constitute an Independent Prognostic Factor of Survival in Myeloma That May Further Differentiate Patients within the ISS Stages.

Rituximab Monotherapy Is an Effective Treatment for Splenic Marginal Zone B-Cell Lymphomas (SMZL).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only